Genetic relatedness between pneumococcal populations originating from the nasopharynx, adenoid, and tympanic cavity of children with otitis media

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3140-3144

  Tonnaer, Edith L ^a   Rijkers, Ger T ^b   Meis, Jacques F ^c   Klaassen, Corné H ^c   Bogaert, Debby ^d   Hermans, Peter W ^d   Curfs, Jo H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ADENOID; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATION; BIOFILM; CHILD; CONTROLLED STUDY; DNA FINGERPRINTING; EARDRUM; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNX; OTITIS MEDIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECRETORY OTITIS MEDIA; STREPTOCOCCUS PNEUMONIAE;

ADENOIDS; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; DNA, BACTERIAL; EAR, MIDDLE; HUMANS; NASOPHARYNX; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 22144453926     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3140-3144.2005     Document Type: Article

References (30)

1. Bogaert, D., P. W. Hermans, P. V. Adrian, H. C. Rumke, and R. de Groot. 2004. Pneumococcal vaccines: an update on current strategies. Vaccine 22: 2209-2220.
2. Brito, D. A., M. Ramirez, and H. de Lancastre. 2003. Serotyping Streptococcus pneumoniae by multiplex PCR. J. Clin. Microbiol. 41:2378-2384.
3. Claverys, J. P., M. Prudhomme, I. Mortier-Barriere, and B. Martin. 2000. Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity? Mol. Microbiol. 35:251-259.
4. Domingue, G. J., and H. B. Woody. 1997. Bacterial persistence and expression of disease. Clin. Microbiol. Rev. 10:320-344.
5. Ehrlich, G. D., R. Veeh, X. Wang, J. W. Costerton, J. D. Hayes, F. Z. Hu, B. J. Daigle, M. D. Ehrlich, and J. C. Post. 2002. Mucosal biofilm formation on middle ear mucosa in the chinchilla model of otitis media. JAMA 287:1710-1715.
6. Givon-Lavi, N., R. Dagan, D. Fraser, P. Yagupsky, and N. Porat. 1999. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin. Infect. Dis. 29: 1274-1280.
7. Hermans, P. W., M. Sluijter, K. Elzenaar, A. van Veen, J. J. Schonkeren, F. M. Nooren, W. J. van Leeuwen, A. J. de Neeling, B. van Klingeren, H. A. Verbrugh, and R. de Groot. 1997. Penicillin-resistant Streptococcus pneumoniae in The Netherlands: results of a 1-year molecular epidemiologic survey. J. Infect. Dis. 175:1413-1422.
8. Hinton, A., R. C. Herdman, C. Hartley, and L. O'Keefe. 1996. The incidence of bacteria in middle ear effusions. Clin. Otolaryngol. 21:158-161.
9. Homoe, P. 2001. Otitis media in Greenland. Studies on historical, epidemiological, microbiological, and immunological aspects. Int. J. Circumpolar Health 60(Suppl. 2):1-54.
10. Huebner, R. E., R. Dagan, N. Porath, A. D. Wasas, and K. P. Klugman. 2000. Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr. Infect. Dis. J. 19:1017-1020.
11. Jero, J., and P. Karma. 1997. Bacterial findings and persistence of middle ear effusion in otitis media with effusion. Acta Otolaryngol. Suppl. 529:22-26.
12. Kadioglu, A., and P. W. Andrew. 2004. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 25:143-149.
13. Karlidag, T., K. Demirdag, I. Kaygusuz, M. Ozden, S. Yalcin, and L. Ozturk. 2002. Resistant bacteria in the adenoid tissues of children with otitis media with effusion. Int. J. Pediatr. Otorhinolaryngol. 64:35-40.
14. Klaassen, C. H., H. A. van Haren, and A. M. Horrevorts. 2002. Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism. J. Clin. Microbiol. 40:101-104.
15. McAvin, J. C., P. A. Reilly, R. M. Roudabush, W. J. Barnes, A. Salmen, G. W. Jackson, K. K. Beninga, A. Astorga, F. K. McCleskey, W. B. Huff, D. Niemeyer, and K. L. Lohman. 2001. A sensitive and specific method for rapid identification of Streptococcus pneumoniae using real-time fluorescence PCR. J. Clin. Microbiol. 39:3446-3451.
16. Neeleman, C., C. H. Klaassen, H. A. de Valk, M. T. de Ruiter, and J. W. Mouton. 2004. Amplified fragment length polymorphism fingerprinting is an effective technique to distinguish streptococcus pneumoniae from other streptococci and an efficient alternative to pulsed-field gel electrophoresis for molecular typing of pneumococci. J. Clin. Microbiol. 42:369-371.
17. Pereira, M. B., M. R. Pereira, V. Cantarelli, and S. S. Costa. 2004. Prevalence of bacteria in children with otitis media with effusion. J. Pediatr. (Rio J.) 80:41-48.
18. Pinar, A., O. Koseoglu, G. Yenisehirli, and B. Sener. 2004. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in a university hospital, Ankara, Turkey. Clin. Microbiol. Infect. 10:718-723.
19. Post, J. C., R. A. Preston, J. J. Aul, M. Larkins-Pettigrew, J. Rydquist-White, K. W. Anderson, R. M. Wadowsky, D. R. Reagan, E. S. Walker, and L. A. Kingsley. 1995. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 273:1598-1604.
20. Post, J. C., G. J. White, J. J. Aul, T. Zavoral, R. M. Wadowsky, Y. Zhang, R. A. Preston, and G. D. Ehrlich. 1996. Development and validation of a multiplex PCR-based assay for the upper respiratory tract bacterial pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Mol. Diagn. 1:29-39.
21. Post, J. C. 2001. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 111:2083-2094.
22. Post, J. C., J. J. Aul, G. J. White, R. M. Wadowsky, T. Zavoral, R. Tabari, B. Kerber, W. J. Doyle, and G. D. Ehrlich. 1996. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am. J. Otolaryngol. 17:106-111.
23. Qvarnberg, Y., and H. Valtonen. 1995. Bacteria in middle ear effusions in children treated with tympanostomy: a 10-year series. Acta Otolaryngol. 115:653-657.
24. Raisanen, S., and L. E. Stenfors. 1992. Bacterial quantification: a necessary complement for the comprehension of middle ear inflammation. Int. J. Pediatr. Otorhinolaryngol. 23:117-124.
25. Rayner, M. G., Y. Zhang, M. C. Gorry, Y. Chen, J. C. Post, and G. D. Ehrlich. 1998. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 279:296-299.
26. Rosenfeld, R. M., L. Culpepper, K. J. Doyle, K. M. Grundfast, A. Hoberman, M. A. Kenna, A. S. Lieberthal, M. Mahoney, R. A. Wahl, C. R. Woods, Jr., and B. L. Yawn. 2004. Clinical practice guideline: otitis media with effusion. Otolaryngol. Head Neck Surg. 130(Suppl. 5):S95-S118.
27. Rubin, L. G., and A. J. Rirvi. 2004. PCR-based assays for detection of Streptococcus pneumoniae serotypes 3, 14, 19F, and 23F in respiratory specimens. Med. Microbiol. 53:595-602.
28. Scharer, G., F. Zaldivar, G. Gonzalez, O. Vargas-Shiraishi, J. Singh, and A. Arrieta. 2003. Systemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin. Clin. Diagn. Lab. Immunol. 10:721-724.
29. Veenhoven, R., D. Bogaert, C. Uiterwaal, C. Brouwer, H. Kiezebrink, J. Bruin, E. IJzerman, P- Hermans, R. de Groot, B. Zegers, W. Kuis, G. Rijkers, A. Schilder, and E. Sanders. 2003. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361:2189-2195.
30. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N. Engl. J. Med. 348:1737-1746.